Influenza immunization

Biologicals

Volumn 25, Issue 2, 1997, Pages 221-225

  Glück, Reinhard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

CONFERENCE PAPER; DRUG EFFICACY; HEALTH CARE POLICY; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS; PRIORITY JOURNAL;

INFLUENZA VIRUS;

EID: 0031171008     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1997.0088     Document Type: Conference Paper

References (22)

1. 1. Lamb RA, Krug MR. Orthomyxoviridae: the viruses and their replication. Chapter 45. In Fields BN, Knipe DM, Howley PM et al., eds, Fields Virology, 3rd Edn. Lipincott-Raven Publishers, Philadelphia, 1996; 1353-1395.
2. 2. Murphy BR, Webster RG. Orthomyxoviruses. Chapter 46. In Fields BN, Knipe DM, Howley PM et al., eds, Fields Virology, 3rd Edn. Lipincott-Raven Publishers, Philadelphia, 1996, 1397-1445.
3. 3. Six HR, Webster RG, Kendal AP et al. Antigenic analysis of H1N1 viruses isolated in the Houstan metropolitan area during four successive seasons. Infect Immun 1983; 42: 433-458.
4. 4. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A virus in the 1957 and 1968 pandemics. J Virol 1989; 63: 4603-4608.
5. 5. Gill PW, Murphy AM. Naturally acquired immunity to influenza type A. Lessons from two coexisting subtypes. Med J Aust 1985; 142; 94-98.
6. 6. Frank AL, Taber LH, Glezen WP et al. Reinfection with influenza A (H3N2) virus in young children and their families. J Infect Dis 1979; 140: 829-836.
7. 7. Epstein SL, Misplan JA, Laswon CM et al. β2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing haemogglutinin and neuraminidase. J Immunol 1993; 150: 5484-5493.
8. 8. Askomas BA, McMichael AJ, Webster RG. The immune response to influenza viruses and the problem of protection against infection. In: ed. Beare AS, Basic and applied influenza research. Boca Raton, Fl: CRC Press, 1982; 159-188.
9. 9. Clements ML, Betts RF, Tierney EL et al. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild type virus. J Clin Microbiol 1986; 24: 157-160.
10. 10. Murphy BR, Kasel JA, Chanok RM. Association of serum antineuraminidase antibody with resistance to influenza in man. N Engl J Med 1972; 286: 1329-1332.
11. 11. Lightman S, Cobbold S, Waldmann H et al. Do L3T4+T cells act as effector cells in protection against influenza virus infection. Immunology 1987; 62: 139-144.
12. 12. McMichael AJ, Gotch FM, Noble GR et al. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983; 309: 13-17.
13. 13. Martin T, Gasparini R, De Donato S et al. Enhanced immunogenicity of Chiron Biocine adjuvanted influenza vaccine in the elderly. Abstract W12-5, for "Options for the Control of Influenza III", Cairns, Australia, 4-9 May 1996.
14. 14. Glück R, Mischler R, Finkel B et al. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet 1994; 344: 160-163.
15. 15. Saurwein-Teissl M, Steger MM, Glück R et al. In vitro studies on the stimulatory effects of a new virosome influenza vaccine on T cells from young and old healthy individuals. Abstract for Symposium of Oesterr. Gesellschaft für Allergologie und Immunologie, Vienna November 21-23, 1996.
16. 16. Glück R. Humoral, mucosal and systemic immunization using immunopotentiating reconstituted influenza virosomes (IRIV) based vaccines. Abstract W12-2, for "Options for the Control of Influenza III", Cairns, Australia, 4-9 May 1996.
17. 17. Bengtsson KL, Sjölander A. Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant. Vaccine 1996; 14/8: 753-760.
18. 18. Wood J, Coombes AGA, Major D et al. Polyactide microparticles as adjuvants for parenteral delivery of influenza vaccine. Abstract W12-1, for "Options for the Control of Influenza III", Cairns, Australia, 4-9 May 1996.
19. 19. Ahmed A'EH, Nicholson KG, Nguyen-Van Tam JS. Reduction in mortality associated with influenza vaccine during 1989-1990 epidemic. Lancet 1995; 346: 591-595.
20. 20. Nichol KL, Margolis KL, Wuorenma J et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-784.
21. 21. Nichol KL, Lind A, Margolis M et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995; 333: 889-893.
22. 22. Nicholson KG, Snachem R, Palache AM. Influenza immunization policies in Europe and the United States. Vaccine 1995; 13/4: 365-368.